Medical adjuncts in IVF: Evidence for clinical practice

Human Fertility

Volumn 12, Issue 1, 2009, Pages 1-13

  Nardo, Luciano G ^a,b   Granne, Ingrid ^c   Stewart, Jane ^d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d Newcastle upon Tyne Hospitals NHS Trust   (United Kingdom)

Author keywords

Aspirin; Heparin; Immune therapy; IVF; Steroids

Indexed keywords

ACETYLSALICYLIC ACID; ESTRADIOL; ESTRADIOL VALERATE; ETANERCEPT; GLUCOCORTICOID; GLYCERYL TRINITRATE; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GROWTH HORMONE; HEPARIN; HLA ANTIGEN; IMMUNOGLOBULIN; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; NITRIC OXIDE; PHOSPHOLIPID ANTIBODY; PLACEBO; PREDNISOLONE; PROGESTERONE; RITODRINE; SALBUTAMOL; SILDENAFIL; STEROID; TERBUTALINE; TUMOR NECROSIS FACTOR ALPHA; UTERUS SPASMOLYTIC AGENT; VASODILATOR AGENT; ESTROGEN; FIBRINOLYTIC AGENT; IMMUNOLOGIC FACTOR;

ADJUVANT THERAPY; ANAPHYLAXIS; ANTIPHOSPHOLIPID SYNDROME; ASEPTIC MENINGITIS; BLOOD PRESSURE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DRUG FEVER; DRUG INDUCED HEADACHE; EMBRYO TRANSFER; EVIDENCE BASED PRACTICE; FERTILIZATION IN VITRO; FLUSHING; GRANULOMATOSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNE FUNCTION TEST; INFECTION; INTRACYTOPLASMIC SPERM INJECTION; KIDNEY FAILURE; LIVE BIRTH; LOW DRUG DOSE; LYMPHOMA; MALAISE; NATURAL KILLER CELL; NAUSEA; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREGNANCY RATE; REVIEW; SIDE EFFECT; SPONTANEOUS ABORTION; SUBFERTILITY; THROMBOEMBOLISM; THROMBOPHILIA; UTERUS CONTRACTILITY; VASODILATATION; ADJUVANT CHEMOTHERAPY; DRUG EFFECT; FEMALE; FEMALE INFERTILITY; IMMUNOLOGY; NIDATION; PREGNANCY; UTERUS CONTRACTION;

ASPIRIN; CHEMOTHERAPY, ADJUVANT; EMBRYO IMPLANTATION; ESTRADIOL; ESTROGENS; FEMALE; FERTILIZATION IN VITRO; FIBRINOLYTIC AGENTS; GLUCOCORTICOIDS; GROWTH HORMONE; HEPARIN; HUMANS; IMMUNOLOGIC FACTORS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY RATE; UTERINE CONTRACTION; VASODILATOR AGENTS;

EID: 67549138282     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.1080/14647270802692169     Document Type: Review

References (117)

1. Abadia-Molina, A. C., Ruiz, C., Montes, M. J., King, A., Loke, Y. W. and Olivares, E. G. (1996) Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. Journal of Reproductive Immunology, 31, pp. 109-123.
2. Abir, R., Garor, R., Felz, C., Nitke, S., Krissi, H. and Fisch, B. (2008) Growth hormone and its receptor in human ovaries from fetuses and adults. Fertility and Sterility, 90:4, pp. 1333-1339.
3. Ando, T., Suganuma, N., Furuhashi, M., Asada, Y., Kondo, I. and Tomoda, Y. (1996) Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. Journal of Assisted Reproduction and Genetics, 13, pp. 776-781.
4. Balasch, J., Creus, M., Fabregues, F., Font, J., Martorell, J. and Vanrell, J. A. (1996) Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertility and Sterility, 65, pp. 655-658.
5. Beckers, N. G. M., Laven, J. S., Eijkemans, M. J. C. and Fauser, B. C. (2000) Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Human Reproduction, 15, pp. 43-49.
6. Beer, A. E., Kwak, J. Y. and Ruiz, J. E. (1996) Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. American Journal of Reproductive Immunology, 35, pp. 376-382.
7. Birkenfeld, A., Mukaida, T., Minichiello, L., Jackson, M., Kase, N. G. and Yemini, M. (1994) Incidence of autoimmune antibodies in failed embryo transfer cycles. American Journal of Reproductive Immunology, 31, pp. 65-68.
8. Bisset, L. R., Lung, T. L., Kaelin, M., Ludwig, E. and Dubs, R. W. (2004) Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. European Journal of Haematology, 72, pp. 203-212.
9. Boomsma, C. M., Keay, S. D. and Macklon, N. S. (2007) Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. The Cochrane Database of Systematic Review
10. Chamley, L. W., Duncalf, A. M., Mitchell, M. D. and Johnson, P. M. (1998) Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet, 352, pp. 1037-1038.
11. Check, J. H., Choe, J. K., Ubelacker, L. and DiAntonio, A. (2001) Maternal/paternal sharing of DQ-α type II histocompatibility antigens not associated with pregnancy outcome following in vitro fertilization (IVF)-embryo transfer (ET). Clinical and Experimental Obstetrics &Gynecology, 28, pp. 142-143.
12. Check, J. H., Graziano, V., Lee, G., Nazari, A., Choe, J. K. and Dietterich, C. (2004) Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clinical and Experimental Obstetrics & Gynecology, 31, pp. 99-102.
13. Coulam, C. B. and Goodman, C. (2000) Increased pregnancy rates after IVF/ ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells. Early Pregnancy, 4, pp. 90-98.
14. Coulam, C. B. and Roussev, R. G. (2003) Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. Journal of Assisted Reproduction and Genetics, 20, pp. 58-62.
15. Coulam, C. B., Krysa, L. W. and Bustillo, M. (1994) Intravenous immunoglobulin for in-vitro fertilization failure. Human Reproduction, 9, pp. 2265-2269.
16. Creus, M., Balasch, J., Fabregues, F., Martorell, J., Boada, M. Penarrubia, J. et al. (1998) Parental human leukocyte antigens and implantation failure after in-vitro fertilization. Human Reproduction, 13, pp. 39-43.
17. Cubillos, J., Lucena, A., Lucena, C., Mendoza, J. C., Ruiz, H. Arango, A. et al. (1997) Incidence of autoantibodies in the infertile population. Early Pregnancy, 3, pp. 119-124.
18. Denis, A. L., Guido, M., Adler, R. D., Bergh, P. A., Brenner, C. and Scott Jr., R. T. (1997) Antiphospholipid antibodies and pregnancy rates and outcome in in-vitro fertilization patients. Fertility and Sterility, 67, pp. 1084-1090.
19. Department of Health (2008) Clinical guidelines for immunoglobulin use, Department of Health, UK
20. Devreker, F., Govaerts, I., Bertrand, E., Van den Bergh, M., Gervy, C. and Englert, Y. (1996) The long acting gonadotrophin releasing hormone analogues impaired the implantation rate. Fertility and Sterility, 65, pp. 122-126.
21. Di Simone, N., Meroni, P. L., de Papa, N., Raschi, E., Caliandro, D. De Carolis, C. S. et al. (2000) Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I. Arthritis and Rheumatism, 43, pp. 140-150.
22. Dor, J., Seidman, D. S., Amudai, E., Bider, D., Levran, D. and Mashiach, S. (1995) Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: A prospective randomized placebo-controlled double-blind study. Human Reproduction, 10, pp. 40-43.
23. Dosiou, C. and Giudice, L. C. (2005) Natural killer cells in pregnancy and recurrent pregnancy loss: Endocrine and immunologic perspectives. Endocrine Reviews, 26, pp. 44-62.
24. Eldar-Geva, T., Wood, C., Lolatgis, N., Rombauts, L., Kovacs, G. Fuscaldo, J. et al. (1999) Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Human Reproduction, 14, pp. 1461-1466.
25. Elram, T., Simon, A., Israel, S., Revel, A., Shveiky, D. and Laufer, N. (2005) Treatment of recurrent IVF failure and human leukocyte antigen similarity by intravenous immunoglobulin. Reproductive BioMedicine Online, 11, pp. 745-749.
26. Empson, M., Lassere, M., Craig, J. and Scott, J. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Systematic Reviews
27. Engmann, L., Diluigi, A., Schmidt, D., Nulsen, J., Maier, D. and Benadiva, C. (2008) The use of gonadotropin-releasing hormone (GnRH-a) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study. Fertility and Sterility, 89, pp. 84-91.
28. Engmann, L., Diluigi, A., Schmidt, D., Benadiva, C., Maier, D. and Nulsen, J. (2008) The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: A prospective randomized study. Fertility and Sterility, 89, pp. 554-561.
29. Fahri, J., Weissman, A., Steinfeld, Z., Shorer, M., Nahum, H. and Levran, D. (2000) Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertility and Sterility, 73, pp. 761-765.
30. Fanchin, R., Righini, C., Olivennes, F., Taylor, S., de Ziegler, D. and Frydman, R. (1998) Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Human Reproduction, 13, pp. 1968-1974.
31. Fasouliotis, S. J., Spandorfer, S. D., Witkin, S. S., Schattman, G., Liu, H. C. Roberts, J. E. et al. (2004) Maternal serum levels of interferon-γ and interleukin-2 soluble receptor-α predict the outcome of early IVF pregnancies. Human Reproduction, 19, pp. 1357-1363.
32. Frattarelli, J. L., McWilliams, G. D., Hill, M. J., Miller, K. A. and Scott Jr., R. T. (2008) Low dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertility and Sterility, 89, pp. 1113-1117.
33. Gelbaya, T. A., Kyrgiou, M., Li, T. C., Stern, C. and Nardo, L. G. (2007) Low-dose aspirin for in vitro fertilization: A systematic review and meta-analysis. Human Reproduction Update, 13, pp. 357-364.
34. Gelbaya, T. A., Kyrgiou, M. and Nardo, L. G. Letter to the editor - reply: 'Is it time for meta-analysis?'. Human Reproduction Update
35. Gelbaya, T. A., Kyrgiou, M., Tsoumpou, I. and Nardo, L. G. (2008) The use of estradiol for luteal phase support in in-vitro fertilization/ intracytoplasmic sperm injection cycles: A systematic review and meta-analysis. Fertility and Sterility, 90, pp. 2116-2125.
36. Geva, E., Yaron, Y., Lessing, J. B., Yovel, I., Vardinon, N. Burke, M. et al. (1994) Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertility and Sterility, 62, pp. 802-806.
37. Geva, E., Vardinon, N., Lessing, J. B., Lerner-Geva, L., Azem, F. Yovel, I. et al. (1996) Organ-specific autoantibodies are possible markers for reproductive failure: A prospective study in an in-vitro fertilization-embryo transfer programme. Human Reproduction, 11, pp. 1627-1631.
38. Geva, E., Amit, A., Lerner-Geva, L., Yaron, Y., Daniel, Y. Schwartz, T. et al. (2000) Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: A prospective study. American Journal of Reproductive Immunology, 43, pp. 36-40.
39. Gorkemli, H., Ak, D., Akyurek, C., Aktan, M. and Duman, S. (2004) Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. Gynecologic and Obstetric Investigation, 58, pp. 140-144.
40. Goswamy, R. K. and Steptoe, P. C. (1988) Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles. Human Reproduction, 3, pp. 721-726.
41. Harper, K., Proctor, M. and Hughes, E. (2003) Growth hormone for in vitro fertilization. Cochrane Database Systematic Review
42. Hasegawa, I., Yamanoto, Y., Suzuki, M., Murakawa, H., Kurabayashi, T. Takakuwa, K. et al. (1998) Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertility and Sterility, 70, pp. 1044-1048.
43. Ho, H. N., Yang, Y. S., Hsieh, R. P., Lin, H. R., Chen, S. U. Chen, H. F. et al. (1994) Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer. American Journal of Obstetrics and Gynecology, 170, pp. 63-71.
44. Hornstein, M. D., Davis, O. K., Massey, J. B., Paulson, R. J. and Collins, J. A. (2000) Antiphospholipid antibodies and in vitro fertilization success: A meta-analysis. Fertility and Sterility, 73, pp. 330-333.
45. Hurst, B. S., Bhojwani, J. T., Marshburn, P. B., Papadakis, M. A., Loeb, T. A. and Matthews, M. L. (2005) Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization. Journal of Experimental & Clinical Assisted Reproduction, 31, pp. 2-8.
46. Hutchinson-Williams, K., Lunenfeld, B., Diamond, M., Lagy, G., Boyers, S. and De Cherney, A. (1989) Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and non-conception cycles in an in vitro fertilization program. Fertility and Sterility, 52, pp. 441-445.
47. Kaider, A. S., Kaider, B. D., Janowicz, P. B. and Roussev, R. G. (1999) Immunodiagnostic evaluation in women with reproductive failure. American Journal of Reproductive Immunology, 42, pp. 335-346.
48. Kalu, E., Bhaskaran, S., Thum, M. Y., Vishwanatha, R., Croucher, C. Sherriff, E. et al. (2008) Serial estimation of Th1:TH2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. American Journal of Reproductive Immunology, 59, pp. 206-211.
49. Katz, U., Achiron, A., Sherer, Y. and Shoenfeld, Y. (2007) Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmunity Reviews, 6, pp. 257-259.
50. Khairy, M., Banerjee, K., El-Toukhy, T., Coomarasamy, A. and Khalaf, Y. (2007) Aspirin in women undergoing in vitro fertilization treatment: A systematic review and meta-analysis. Fertility and Sterility, 88, pp. 822-831.
51. Kikuchi, K., Shibahara, H., Hirano, Y., Kohno, T., Hirashima, C. Suzuki, T. et al. (2003) Antinuclear antibody reduces the pregnancy rate in the first IVF-ET treatment cycle but not the cumulative pregnancy rate without specific medication. American Journal of Reproductive Immunology, 50, pp. 363-367.
52. Kim, C. H., Chae, H. D. and Chang, Y. S. (1999) Pyridostigmine cotreatment for controlled ovarian hyperstimulatiom in low responders undergoing in vitro fertilization embryo transfer. Fertility and Sterility, 71, pp. 652-657.
53. Knutzen, V., Stratton, C. J., Sher, G., McNamee, P. I., Huang, T. T. and Soto-Albors, C. (1992) Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: A descriptive study. Fertility and Sterility, 57, pp. 156-162.
54. Kozer, E., Nikfar, S., Costei, A., Boskovic, R., Nulman, I. and Koren, G. (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis. American Journal of Obstetrics & Gynecology, 187, pp. 1623-1630.
55. Kucuk, T., Kozinoglu, H. and Kaba, A. (2008) Growth hormone co-treatment within a GnRH-agonist long protocol in patients with poor ovarian response: A prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics, 25, pp. 123-127.
56. Kutteh, W. H., Yetman, D. L., Chantilis, S. J. and Crain, J. (1997) Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: Role of heparin and aspirin. Human Reproduction, 12, pp. 1171-1175.
57. Kutteh, W. H., Yetman, D. L., Carr, A. C., Beck, L. A. and Scott Jr., R. T. (1999) Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertility and Sterility, 71, pp. 843-848.
58. Kutteh, W. H., Schoolcraft, W. B. and Scott Jr., R. T. (1999) Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Human Reproduction, 14, pp. 2886-2890.
59. Kwak-Kim, J. Y., Ching-Bang, H. S., Ng, S. C., Ntrivalas, E. I., Mangubat, C. P. Beaman, K. D. et al. (2003) Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Human Reproduction, 18, pp. 767-773.
60. Lee, S. R., Park, E. J., Kim, S. H., Chae, H., Kim, C. H. and Kang, B. M. (2007) Influence of antiphospholipid antibodies on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer. American Journal of Reproductive Immunology, 57, pp. 34-39.
61. Lesny, P., Killick, S. R., Tetlow, R. L., Robinson, J. and Maguiness, S. D. (1998) Uterine junctional zone contractions during assisted reproduction cycles. Human Reproduction Update, 4, pp. 440-445.
62. Lewin, A., Benshushan, A., Mezker, E., Yanai, N., Schenker, J. and Goshen, R. (1994) The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: A comparative study between progesterone alone and estrogen and progesterone support. Fertility and Sterility, 62, pp. 212-225.
63. Lim, W. and Crowther, M. A. (2007) Antiphospholipid antibiodies: A critical review of the literature. Current Opininon in Hematology, 14, pp. 494-499.
64. Lok, I. H., Yip, S. and Cheung, L. P. (2004) Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: A prospective, randomized, double-blind, placebo-controlled trial. Fertility and Sterility, 81, pp. 556-561.
65. Luborsky, J., Llanes, B., Davies, S., Binor, Z., Radwanska, E. and Pong, R. (1999) Ovarian autoimmunity: Greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clinical Immunology, 90, pp. 368-374.
66. Lukaszuk, K., Liss, J., Lukaszuk, M. and Maj, B. (2005) Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertility and Sterility, 83, pp. 1372-1376.
67. Martin-Villa, J. M., De Juan, D., Vicario, J. L., Luque, I. M., Alvarez, E. Cortes-Prieto, J. et al. (1993) HLA class I, class II, and class III antigen sharing is not found in couples with unexplained infertility. International Journal of Fertility and Menopausal Studies, 38, pp. 280-288.
68. Matteo, M. G., Greco, P., Rosenberg, P., Mestice, A., Baldini, D. Falagario, T. et al. (2007) Normal percentage of CD56bright natural killer cells in young patients with a history of repeated unexplained implantation failure after in vitro fertilization cycles. Fertility and Sterility, 88, pp. 990-993.
69. Miyakis, S., Lockshin, M. D., Atsumi, T., Branch, D. W., Brey, R. L. Cervera, R. et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, pp. 295-306.
70. Moffett-King, A. (2002) Natural killer cells and pregnancy. Nature Reviews Immunology, 2, pp. 656-663.
71. Morizaki, N., Morizaki, J., Hayashi, R. H. and Garfield, R. E. (1989) A functional and structural study of the innervation of the human uterus. American Journal of Obstetrics and Gynecology, 160, pp. 218-228.
72. National Institute for Health and Clinical Excellence (2004) Fertility: assessment and treatment for people with fertility problems. Clinical Guideline, 11, p. 12.3.
73. Negro, R., Formoso, G., Coppola, L., Presicce, G., Mangieri, T. Pezzarossa, A. et al. (2007) Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: The role of autoimmunity and thyroid function. Journal of Endocrinological Investigation, 30, pp. 3-8.
74. Nelson, S. M. and Greer, I. A. (2008) The potential role of heparin in assisted conception. Human Reproduction Update, 14, pp. 623-645.
75. Ng, S. C., Gilman-Sachs, A., Thaker, P., Beaman, K. D., Beer, A. E. and Kwak-Kim, J. (2002) Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. American Journal of Reproductive Immunology, 48, pp. 77-86.
76. Nordlander, C., Fuchs, T., Hammarstrom, L. and Smith, C. I. (1983) Human leukocyte antigens group A in couples with unexplained infertility. Fertility and Sterility, 40, pp. 60-65.
77. Ohl, J., Lefebvre-Maunoury, C., Wittemer, C., Nisand, G., Laurent, M. C. and Hoffmann, P. (2002) Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Human Reproduction, 17, pp. 2615-2620.
78. Okazaki, M., Matsuyama, T., Kohno, T., Shindo, H., Koji, T. Morimoto, Y. et al. (2005) Induction of epithelial cell apoptosis in the uterus by a mouse uterine ischemia-reperfusion model: Possible involvement of tumor necrosis factor-alpha. Biology of Reproduction, 72, pp. 1282-1288.
79. Omu, A. E., al-Qattan, F., Ismail, A. A., al-Taher, S. and al-Busiri, N. (1999) Relationship between unexplained infertility and human leukocyte antigens and expression of circulating autogeneic and allogeneic antisperm antibodies. Clinical and Experimental Obstetrics and Gynecology, 26, pp. 199-202.
80. Opatrny, L., David, M., Kahn, S. R., Shrier, I. and Rey, E. (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: A meta-analysis. Journal of Rheumatology, 33, pp. 2214-2221.
81. Pakkila, M., Rasanen, J., Heinonen, S., Tinkanen, H., Tuomivaara, L. Makikallio, K. et al. (2005) Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: A randomized, placebo-controlled double-blind study. Human Reproduction, 20, pp. 2211-2214.
82. Patrono, C., Garcia Rodriguez, L.A., Landolfi, R. and Baigent, C. (2005) Low-dose aspirin for the prevention of atherosclerosis. New England Journal of Medicine, 353, pp. 2373-2383.
83. Pinheiro, O. L., Cavagna, M., Baruffi, R. L. R., Mauri, A. L., Petersen, C. and Franco Jr., J. G. (2003) Administration of β2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles. Journal of Assisted Reproduction and Genetics, 20, pp. 513-516.
84. Pires, E. S., Meherji, P. K., Vaidya, R. R., Parikh, F. R., Ghosalkar, M. N. and Khole, V. V. (2007) Specific and sensitive immunoassays detect multiple anti-ovarian antibodies in women with infertility. The Journal of Histochemistry and Cytochemistry, 55, pp. 1181-1190.
85. Qublan, H. S., Eid, S. S., Ababneh, H. A., Amarin, Z. O., Smadi, A. Z. Al-Khafaji, F. F. et al. (2006) Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Human Reproduction, 21, pp. 2694-2698.
86. Quenby, S., Bates, M., Doig, T., Brewster, J., Lewis-Jones, D. I. Johnson, P. M. et al. (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Human Reproduction, 14, pp. 2386-2391.
87. Revelli, A., Dolfin, E., Gennarelli, G., Lantieri, T., Massobrio, M. Holte, J. G. et al. (2008) Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: A prospective, randomized study. Fertility and Sterility, 90, pp. 1685-1691.
88. Rogolino, A., Coccia, M. E., Fedi, S., Gori, A. M., Cellai, A. P. Scarselli, G. F. et al. (2003) Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: Possible association with clinical outcome. Blood Coagulation & Fibrinolysis, 14, pp. 277-282.
89. Royal College of Obstetricians and Gynaecologists. Scientific Advisory Committee Opinion Paper 5 (2008) Immunological testing and interventions for reproductive failure.
90. Rubinstein, M., Marazzi, A. and Polak, D. F. (1999) Low dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation and pregnancy rates in patients undergoing in vitro fertilization: A prospective, randomized double blind placebo controlled assay. Fertility and Sterility, 71, pp. 825-829.
91. Ruopp, M. D., Collins, T. C., Whitcomb, B. W. and Schisterman, E. F. (2008) Evidence of absence or absence of evidence? A re-analysis of the effects of low-dose aspirin in in-vitro fertilization. Fertility and Sterility, 90, pp. 71-76.
92. Schenk, L. M., Butler, L., Monis, J. P., Cox, B., Leete, J. Abuhamed, A. et al. (1996) Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. Fifty-Second Annual Meeting of the American Society for Reproductive Medicine Boston, MA, USA
93. Sengupta, J., Dhawan, L., Lalitkumar, P. G. L. and Ghosh, D. (2005) Nitric oxide in blastocyst implantation in the rhesus monkey. Reproduction, 130, pp. 321-332.
94. Serna, J., Cholquevilque, J. L., Cela, V., Martinez-Salazar, J., Requena, A. and Garcia-Velasco, J. A. (2008) Estradiol supplementation during the luteal phase of IVF-ICSI patients: A randomized, controlled trial. Fertility and Sterility, 90, pp. 2190-2195.
95. Shaker, A. G., Fleming, R., Jamieson, M. E., Yates, R. W. and Coutts, J. R. (1993) Assessments of embryo transfer after in-vitro fertilization: effects of glyceryl trinitrate. Human Reproduction, 8, pp. 1426-1428.
96. Sher, G. and Fisch, J. D. (2000) Vaginal sildenafil (Viagra): A preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction, 15, pp. 806-809.
97. Sher, G., Maassarani, G., Zouves, C., Feinman, M., Sohn, S. Matzner, W. et al. (1998) The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. American Journal of Reproductive Immunology, 39, pp. 223-225.
98. Sher, G., Matzner, W., Feinman, M., Maassarani, G., Zouves, C. Chong, P. et al. (1998) The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. American Journal of Reproductive Immunology, 40, pp. 74-82.
99. Sher, G., Zouves, C., Feinman, M., Maassarani, G., Matzner, W. Chong, P. et al. (1998) A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. American Journal of Reproductive Immunology, 39, pp. 391-394.
100. Sherer, Y., Levy, Y., Langevitz, P., Rauova, L., Fabrizzi, F. and Shoenfeld, Y. (2001) Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology, 62, pp. 133-137.
101. Smitz, J., Bourgain, C., Van Waesberghe, L., Camus, M., Devroey, P. and Van Steirteghem, A. (1993) A prospective randomized study on estradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Human Reproduction, 8, pp. 40-45.
102. Steer, C. V., Campbell, S., Tan, S. L., Crayford, T., Millis, C. Mason, B. A. et al. (1992) The use of transvaginal color flow imaging after in vitro fertilization identifies optimum uterine conditions before embryo transfer. Fertility and Sterility, 57, pp. 372-376.
103. Stephenson, M. D. and Fluker, M. R. (2000) Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: A randomized, placebo-controlled Canadian trial. Fertility and Sterility, 74, pp. 1108-1113.
104. Stern, C., Chamley, L., Hale, L., Kloss, M., Speirs, A. and Baker, H. W. (1998) Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertility and Sterility, 70, pp. 938-944.
105. Stern, C., Chamley, L., Norris, H., Hale, L. and Baker, H. W. (2003) A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertility and Sterility, 80, pp. 376-383.
106. Taniguchi, F. (2005) Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies. Journal of Reproductive Medicine, 50, pp. 383-388.
107. Tay, P. Y. S. and Lenton, E. A. (2003) Inhibition of progesterone secretion by oestradiol administration in the luteal phase of assisted conception cycles. Medical Journal of Malaysia, 58, pp. 187-195.
108. Thum, M. Y., Bhaskaran, S., Abdalla, H. I., Ford, B., Sumar, N. Shehata, H. et al. (2004) An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Human Reproduction, 19, pp. 2395-2400.
109. Thum, M. Y., Abdalla, H. I., Bhaskaran, S., Harden, E. L., Ford, B. Sumar, N. et al. (2007) The relationship of systemic TNF-α and IFN-γ with IVF treatment outcome and peripheral blood NK cells. American Journal of Reproductive Immunology, 57, pp. 210-217.
110. Urman, B., Mercan, R., Alatas, C., Balaban, B., Isiklar, A. and Nuhoglu, A. (2000) Low dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: A prospective randomized study. Journal of Assisted Reproduction and Genetics, 17, pp. 586-590.
111. van Gestel, I., Ijland, M. M., Hoogland, H. J. and Evers, J. L. (2003) Endometrial wave-like activity in the non-pregnant uterus. Human Reproduction Update, 9, pp. 131-138.
112. Waldenstrom, U., Hellberg, D. and Nilsson, S. (2004) Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: A randomized, prospective study. Fertility and Sterility, 81, pp. 1560-1564.
113. Weckstein, L. N., Jacobson, A., Galen, D., Hampton, K. and Hammel, J. (1997) Low-dose aspirin for oocyte donation recipients with a thin endometrium: Prospective, randomized study. Fertility and Sterility, 68, pp. 927-930.
114. Wilson, W. A., Gharavi, A. E., Koike, T., Lockshin, M. D., Branch, D. W. Piette, J. C. et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis and Rheumatism, 42, pp. 1309-1311.
115. Yetman, D. L., Kutteh, W. H., Castorena, R., Brown, C. and Baskin, L. (1997) Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alpha-fetoprotein. Journal of Reproductive Immunology, 33, pp. 71-81.
116. Younis, S., Ezra, Y., Sherman, Y., Simon, A., Schencker, G. and Laufer, N. (1994) The effect of estradiol depletion during the luteal phase on endometrium development. Fertility and Sterility, 62, pp. 103-107.
117. Zhang, X., Wang, H. M., Lin, H. Y., Liu, G. Y., Li, Q. L. and Zhu, C. (2004) Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: Role of nitric oxide. Placenta, 25, pp. 243-252.